ChemicalBook > CAS DataBase List > HAMI3379

HAMI3379

Product Name
HAMI3379
CAS No.
712313-35-4
Chemical Name
HAMI3379
Synonyms
HAMI3379;(Rac)-HAMI 3379;HRJWSEPIRZRGCL-UHFFFAOYSA-N;(Rac) HAMI 3379,(Rac)HAMI 3379;N-(3-carboxy-cyclo-hexyl-)-5-carboxy-2-(cyclo-hexyl-oxy-butyl-oxy-phenyl-propyl-oxy-)-benz-amide;Benzoic acid, 3-[[(3-carboxycyclohexyl)amino]carbonyl]-4-[3-[4-[4-(cyclohexyloxy)butoxy]phenyl]propoxy]-
CBNumber
CB62591197
Molecular Formula
C34H45NO8
Formula Weight
595.72
MOL File
712313-35-4.mol
More
Less

HAMI3379 Property

Boiling point:
797.7±60.0 °C(Predicted)
Density 
1.24±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
≤5mg/ml in ethanol;20mg/ml in DMSO;20mg/ml in dimethyl formamide
form 
crystalline solid
pka
4.20±0.10(Predicted)
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
10580
Product name
HAMI3379
Purity
≥90%
Packaging
1mg
Price
$48
Updated
2023/01/06
Cayman Chemical
Product number
10580
Product name
HAMI3379
Purity
≥90%
Packaging
5mg
Price
$210
Updated
2023/01/06
Cayman Chemical
Product number
10580
Product name
HAMI3379
Purity
≥90%
Packaging
10mg
Price
$373
Updated
2023/01/06
Cayman Chemical
Product number
10580
Product name
HAMI3379
Purity
≥90%
Packaging
25mg
Price
$814
Updated
2023/01/06
AK Scientific
Product number
7522CR
Product name
3-[(3-Carboxycyclohexyl)carbamoyl]-4-[3-[4-(4-cyclohexyloxybutoxy)phenyl]propoxy]benzoicAcid
Packaging
1mg
Price
$158
Updated
2021/12/16
More
Less

HAMI3379 Chemical Properties,Usage,Production

Definition

ChEBI: Benzoic acid, 3-[[(3-carboxycyclohexyl)amino]carbonyl]-4-[3-[4-[4-(cyclohexyloxy)butoxy]phenyl]propoxy]- is an organooxygen compound and an organonitrogen compound. It is functionally related to a gamma-amino acid.

Biological Activity

hami3379, as a potent cyslt2 receptor antagonist, blocks radioligand binding of ltd4 to cyslt2 and cyslt1 receptor cell lines. in a cyslt2 receptor reporter cell line, hami3379 antagonizes ltd4- and ltc4-induced intracellular calcium mobilization. in contrast, hami3379 exhibits very low potency on a cyslt1 receptor reporter cell line. additionally, hami3379 does not exhibit any agonistic activity on both cyslt2 and cyslt1 receptor cell lines. cyslts ltc4 and ltd4 are potent mediators of hypersensitivity and asthma reactions. they increase the permeability of microvascular, elicit bronchoconstriction, functioning as vasoconstrictors of coronary arteries, which are transduced by cyslt1 and cyslt2.

in vitro

in a murine microglial cell line (bv-2 cells), hami3379 effectively dampened lipopolysaccharide (lps) -induced phagocytosis. in addition, hami3379 dose-dependently decreased the lps-induced overproduction of proinflammatory cytokines which included tumor necrosis factor-α (tnf-α), interleukin-1β (il-1β), and interleukin-6 [1].

in vivo

male sprague–dawley rats were injected intraperitoneally with hami 3379 at a dose of 0.1 mg/kg at 0, 1, 2 and 4 h. after 24 h, hami 3379 attenuated the acute brain injury after middle cerebral artery occlusion (mcao). in addition, hami 3379 weakened the neurological deficits and decreased brain edema, infarct volume, and neuronal loss and degeneration after maco. moreover, hami 3379 blocked the release of interferon-γ, cytokines il-1β, and tnf-α into the cerebrospinal fluid and serum after maco [2].

IC 50

37.9 nm: blocks radioligand binding of leukotriene d4 (ltd4) to cysteinyl leukotriene 2 (cyslt2).

References

[1]. chen, l., yang, y., li, c., zhang, s., zheng, w., wei, e., & zhang, l. cyslt2 receptor mediates lipopolysaccharide-induced microglial inflammation and consequent neurotoxicity in vitro. brain research. 2015; 1624: 433-445.
[2]. shi, q., wang, h., liu, z., fang, s., song, x., & lu, y. et al. hami 3379, a cyslt2r antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats. neuroscience. 2015; 291: 53-69.

HAMI3379 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

HAMI3379 Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32165
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11217
Advantage
58
ChengDu SinoStandards Bio-Tech Co.,Ltd. ,
Tel
028-83243028 19136088901
Email
sinostandards@163.com
Country
China
ProdList
4985
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24647
Advantage
58
Hubei Aiputi Bioengineering Co., Ltd.
Tel
17762444226
Email
d17762444226@163.com
Country
China
ProdList
2402
Advantage
58
TargetMol Chemicals Inc.
Tel
+8613564774135
Email
zijue.cai@tsbiochem.com
Country
United States
ProdList
19885
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58

712313-35-4, HAMI3379Related Search:


  • HAMI3379
  • HRJWSEPIRZRGCL-UHFFFAOYSA-N
  • (Rac)-HAMI 3379
  • (Rac) HAMI 3379,(Rac)HAMI 3379
  • N-(3-carboxy-cyclo-hexyl-)-5-carboxy-2-(cyclo-hexyl-oxy-butyl-oxy-phenyl-propyl-oxy-)-benz-amide
  • Benzoic acid, 3-[[(3-carboxycyclohexyl)amino]carbonyl]-4-[3-[4-[4-(cyclohexyloxy)butoxy]phenyl]propoxy]-
  • 712313-35-4
  • C34H45NO8